Bodyline's weight loss injection programmes offer safe, clinically supervised weight loss pens using the latest GLP-1 / GIP medications. These evidence-based treatments are designed to support sustainable weight loss by helping to regulate appetite and improve metabolic health. You will feel fuller for longer, have reduced food noise, increased food satiety, decreased food cravings and improved blood sugar control.
Our experienced weight health clinical team understands the challenges of weight management. That's why our personalised approach ensures you are fully supported at every stage of your weight loss journey, from initial assessment through to ongoing monitoring and guidance.
Whether your goal is to lose a little weight or a more significant transformation, our dedicated weight loss nurses provide expert care and continuous support. Alongside your weight loss jabs, you'll receive tailored lifestyle advice, exercise recommendations, nutrition guidance, and practical strategies to help you build healthier habits and achieve long-term results.
Bodyline also supports patients throughout the weight maintenance phase, helping to promote long-term positive weight health and address concerns around weight regain.
At Bodyline, your safety, wellbeing, and success come first. Begin your journey with confidence, knowing you're supported by trusted weight health clinical professionals every step of the way.
*Extra charges apply for initial onboarding and for new home customer starter kit
Achieve your weight loss goals with Bodyline's medically supervised weight loss programmes and one of the latest weight loss injection prescriptions. Our programmes combine clinically proven treatments with personalised support to help you lose and maintain weight safely, sustainably, and confidently.
Weight loss injection treatments from Bodyline are safe and clinically approved medications designed to support weight loss by regulating appetite, improving metabolic function, and helping manage cravings. At Bodyline, we specialise in GLP-1 / GIP injections, leading treatments for medically supervised weight management.
These injections are prescribed by our specialist weight health nurses after a detailed consultation, ensuring your treatment is safe, personalised, and effective.
If safe and eligible to start a nurse led Bodyline weight loss injection programme your clinician will discuss the weight loss injection medication available. You could be prescribed a GLP-1 Wegovy or a combined GLP-1 / GIP weight loss pen Mounjaro.
Safe, Affordable and Supported GLP-1 / GIP Weight Loss Jab Programmes
The Wegovy slimming injection is semaglutide and is a convenient once-weekly self-administered weight loss treatment that comes in the form of a pre-filled pen. It is approved by NICE and licensed for managing overweight and obesity. It is designed to suppress appetite by mimicking a hormone found in the stomach called GLP-1, making you feel full for longer.
This easy-to-use and painless injection is effective and can achieve up to 15% reduction in body weight after one year. It can safely be prescribed by Bodyline, which is a specialist CQC registered clinic, either via video or in-clinic consultation alongside a personalised weight loss plan.
Ozempic is a once-weekly self administered weight loss injection that is licensed only for the treatment of type 2 diabetes. It is a GLP-1 and has the same semaglutide ingredient as Wegovy. Ozempic, when combined with lifestyle changes also supports weight loss. It reduces hunger and food cravings allowing you to lose weight and more easily change your eating habits.
Weight loss injections should only be prescribed by a trained clinician and to ensure safety as part of a supported weight loss programme provided by a CQC registered clinic such as Bodyline.
Mounjaro, also known as tirzepatide, is a self-administered once a week weight loss injection that works by imitating the effects of GLP-1 in the body, a hormone that is generally released following mealtimes to promote feelings of fullness and satiety.
Mounjaro helps to regulate blood sugar levels, reduce appetite, and promote weight loss through reduced caloric intake. Thanks to its incredible weight results, with up to 25% body weight loss and promising impact on obesity, it has recently been approved by MRHA in UK to treat of obesity.
To ensure safe and effective use, Mounjaro should only be prescribed as part of a supported weight loss programme at a CQC registered clinic such as Bodyline.
Saxenda Bodyline SlimPen offers a convenient and effective approach to weight management. This self-administered daily injection, administered painlessly, acts as a powerful appetite suppressant. To ensure safe and optimal use, Saxenda Bodyline SlimPen can only be prescribed by a qualified healthcare provider at a CQC registered clinic. This can be done either through a video consultation or an in-person visit. Additionally, a personalised Bodyline Weight Loss plan is essential for maximising weight loss results and achieving a healthier lifestyle.
Weight loss pens including Mounjaro (tirzepatide) and Wegovy (semaglutide), are innovative injectable medications used to support the management of obesity and type 2 diabetes.
These treatments work by mimicking naturally occurring hormones involved in appetite regulation, blood sugar control, and digestion. Mounjaro uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, while Wegovy targets the GLP-1 receptor alone — helping to reduce hunger, increase feelings of fullness, controlling blood sugar and supporting sustained weight loss when used as part of a medically supervised and personalised Bodyline weight loss injection programme.
Mounjaro and Wegovy weight loss pens gently signal to the part of the brain that controls appetite, helping you feel full more quickly and for longer. Many people notice they're satisfied with a feeling of 'satiety' with smaller portions and feel less hungry between meals.
GLP-1/GIP treatments slow digestion slightly, meaning food stays in your stomach longer. This helps reduce the urge to snack and can make it easier to go longer between meals without feeling uncomfortable hunger.
By influencing the brain's reward system, these treatments can reduce cravings for high-calorie or comfort foods. Many patients describe feeling calmer around food, with fewer emotional or impulsive eating urges.
GLP-1 / GIP treatments help maintain "fullness" signals, even as you lose weight. This makes weight loss feel more manageable and helps prevent the rebound hunger that often comes with dieting.
Mounjaro and Wegovy work alongside your daily habits, helping you make longer-term healthier choices more easily. This support makes it simpler to adopt and sustain healthier lifestyle, diet, nutrition and exercise routines.
GLP-1 / GIP receptor agonists, such as Mounjaro (tirzepatide) and Wegovy (semaglutide), do more than support weight loss. Clinical research and Bodyline patient feedback has shown many additional benefits for the body
These medications help your pancreas release insulin in response to meals and reduce glucose production, keeping blood sugar more stable, energy levels steady and reducing the risk of diabetes complications.
GLP-1 / GIP medications your body release insulin when it's needed and respond to it better, which helping regulate energy and keeps your blood sugar or glucose balanced.
They can help lower "bad" fats in your blood (triglycerides) and improve cholesterol, supporting heart and metabolic health.
Some studies suggest that these medications may have anti-inflammatory effects which could benefit overall metabolic and cardiovascular health.
As these jabs can help to regulate blood sugar, insulin and appetite they improve markets of metabolic syndrome.
Evidence shows GLP1 / GIP therapies may help preserve kidney function in people with type 2 diabetes.
Research has shown to reduce liver fat in people with fatty liver disease (NAFLD) supporting liver function.
Research suggests these medications may reduce some risk factors for cardiovascular / heart disease.
They influence hormones and metabolism, helping your body use energy more efficiently.
By stabilising blood sugar and improving metabolism, patients sometimes report steadier energy throughout the day
At Bodyline Medical Wellness Clinics, the UK's Number 1 specialist weight loss clinic group, we help people transform their health and wellbeing. Our advanced weight loss injection programmes use the latest self-injectable GLP-1 and GIP receptor agonists pens, including Mounjaro (tirzepatide) and Wegovy (semaglutide).
These weight loss medications are clinically proven to help you reach your weight and health goals safely and effectively.
We are proud to play a trusted role in advancing the latest weight loss medications through our Clinical Trials Service. By taking part in our trials, you will have the opportunity to access cutting-edge treatments under the expert care of Bodyline's clinical team, while helping shape the future of medical weight loss.
I’ve put so many people onto Bodyline. One friend of mine, another mum from school started to use it and she’s already lost 2 stone! It works so quickly.
I had just always struggled, and I was sick of the way that I was. The dieting never went well. But then I saw how well my mum had done, and I was like you know what, I'm going to try Bodyline.
